Abstract |
There are very few drugs effective in the treatment of diffuse scleroderma and therefore we conducted an open study with gamma interferon. Among 20 diffuse scleroderma, evolving since less than 3 years, an improvement was observed in 8 patients. There was no serious side effect. Survival of these 20 patients was 85% at 5 years.
|
Authors | O Blétry, R Laraki, J Cabane, C Francès, J C Piette, M Soubrier, B Wechsler, C de Gennes, C Valat, J Cosserat |
Journal | La Revue de medecine interne
(Rev Med Interne)
Vol. 14
Issue 10
Pg. 978
( 1993)
ISSN: 0248-8663 [Print] France |
Vernacular Title | Résultats à long terme du traitement des sclérodermies systémiques diffuses par l'interféron gamma. |
PMID | 8009071
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Aged
- Drug Evaluation
- Female
- Humans
- Interferon-gamma
(therapeutic use)
- Male
- Middle Aged
- Scleroderma, Systemic
(therapy)
- Time Factors
|